COVID-19 vaccines pricing policy options for low-income and middle- income countries.

Guzman, Javier; Hafner, Tamara; Maiga, Lalla Arkia; Giedion, Ursula

Guzman, Javier; Hafner, Tamara; Maiga, Lalla Arkia; Giedion, Ursula.

Guzman J; USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, Virginia, USA jguzman@mtapsprogram.org.
Hafner T; USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, Virginia, USA.
Maiga LA; USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, Virginia, USA.
Giedion U; Inter-American Development Bank, Washington, District of Columbia, USA.

BMJ Glob Health ; 6(3)2021 03.

Article in English | MEDLINE | ID: covidwho-1138337

Subject(s)

COVID-19 Vaccines/economics; COVID-19; Developing Countries/economics; Health Policy/economics; COVID-19/economics; COVID-19/prevention & control; Global Health/economics; Humans; Pandemics

Keywords

COVID-19; health policy; public health; vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Developing Countries / COVID-19 Vaccines / COVID-19 / Health Policy Topics: Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Bmjgh-2021-005347

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google